We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDTX icon
1301
Black Diamond Therapeutics
BDTX
$129M
$568K 0.01%
+46,603
New +$921K
KVSA
1302
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$567K 0.01%
57,313
CTBI icon
1303
Community Trust Bancorp
CTBI
$1.38B
$565K 0.01%
13,999
+4,660
+50% +$204K
HCA icon
1304
HCA Healthcare
HCA
$92.6B
$565K 0.01%
2,735
-4,837
-64% -$986K
IGMS
1305
DELISTED
IGM Biosciences
IGMS
$565K 0.01%
6,793
+391
+6% +$29K
SITC icon
1306
SITE Centers
SITC
$158M
$564K 0.01%
+47,993
New +$550K
VERU icon
1307
Veru
VERU
$47.2M
$564K 0.01%
6,987
-1,453
-17% -$128K
GIII icon
1308
G-III Apparel Group
GIII
$1.4B
$563K 0.01%
17,144
-18,704
-52% -$605K
CERS icon
1309
Cerus
CERS
$546M
$562K 0.01%
+95,126
New +$558K
KIE icon
1310
State Street SPDR S&P Insurance ETF
KIE
$712M
$561K 0.01%
+14,567
New +$567K
DSPG
1311
DELISTED
DSP Group Inc
DSPG
$560K 0.01%
+37,830
New +$565K
VINP icon
1312
Vinci Compass Investments Ltd
VINP
$615M
$559K 0.01%
38,541
+5,278
+16% +$69.2K
TS icon
1313
Tenaris
TS
$27.2B
$557K 0.01%
25,422
+14,735
+138% +$333K
BBBY
1314
DELISTED
Bed Bath & Beyond Inc
BBBY
$557K 0.01%
16,738
-9,351
-36% -$260K
RCM
1315
CALL
DELISTED
R1 RCM Inc. Common Stock
RCM
$556K 0.01%
+25,000
New +$604K
GFX.U
1316
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$556K 0.01%
54,600
IBOC icon
1317
International Bancshares
IBOC
$4.4B
$554K 0.01%
12,910
+3,439
+36% +$161K
MHO icon
1318
M/I Homes
MHO
$3.86B
$554K 0.01%
+9,439
New +$609K
RXT icon
1319
Rackspace Technology
RXT
$833M
$554K 0.01%
+28,240
New +$625K
THFF icon
1320
First Financial Corp
THFF
$940M
$554K 0.01%
+13,584
New +$603K
TWI icon
1321
Titan International
TWI
$463M
$554K 0.01%
65,381
-134,760
-67% -$1.31M
CCOI icon
1322
Cogent Communications
CCOI
$503M
$553K 0.01%
+7,194
New +$534K
GTES icon
1323
Gates Industrial Corp
GTES
$6.73B
$553K 0.01%
30,591
-40,604
-57% -$710K
EVOP
1324
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$553K 0.01%
+19,931
New +$569K
IPG
1325
DELISTED
Interpublic Group of Companies
IPG
$552K 0.01%
16,988
-154,554
-90% -$4.94M

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.